This article was originally published in The Gray Sheet
Executive SummaryShareholders meeting is set for March 30 to vote on Summit Technology's proposed $86.6 mil. acquisition of the ophthalmic laser manufacturer, announced in October ("The Gray Sheet" Nov. 9, 1998, p. 7). Summit's shareholder meeting is set for the same day. Autonomous notes that scrutiny of the deal by the Securities and Exchange Commission has delayed closure, originally anticipated in January
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.